Skip to Content

Cosentyx Side Effects

Generic Name: secukinumab

Note: This document contains side effect information about secukinumab. Some of the dosage forms listed on this page may not apply to the brand name Cosentyx.

In Summary

Common side effects of Cosentyx include: infection and nasopharyngitis. Other side effects include: diarrhea. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to secukinumab: subcutaneous powder for solution, subcutaneous solution

Along with its needed effects, secukinumab (the active ingredient contained in Cosentyx) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking secukinumab:

More common Less common
  • Body aches or pain
  • chills
  • cough
  • difficulty with breathing
  • ear congestion
  • hives or welts, itching, or skin rash
  • loss of voice
  • redness of the skin
Incidence not known

For Healthcare Professionals

Applies to secukinumab: subcutaneous powder for injection, subcutaneous solution

Dermatologic

Uncommon (0.1% to 1%): Tinea pedis, urticaria[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, oral herpes
Uncommon (0.1% to 1%): Oral candidiasis
Frequency not reported: Exacerbation of inflammatory bowel disease (IBD)[Ref]

Hypersensitivity

Rare (less than 0.1%): Anaphylaxis[Ref]

Immunologic

Uncommon (0.1% to 1%): Immunogenicity
Frequency not reported: Candida infections, herpes viral infections, staphylococcal skin infections, infections requiring treatment (increased as serum concentration of this drug is increased), neutropenia[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis (up to 12.3%)
Common (1% to 10%): Upper respiratory tract infection, rhinitis, pharyngitis, rhinorrhea[Ref]

Hematologic

Uncommon (0.1% to 1%): Neutropenia[Ref]

Ocular

Uncommon (0.1% to 1%): Conjunctivitis[Ref]

Other

Uncommon (0.1% to 1%): Otitis externa[Ref]

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. "Product Information. Cosentyx (secukinumab)." Novartis Pharmaceuticals, East Hanover, NJ.

3. Cerner Multum, Inc. "Australian Product Information." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide